PECAM1 and cancer: Our data showed the involvement of CD31- or CD34-positive cancer cells in the formation of VM channels and parallel expression of CD31 and CD34 with tumor progression, thereby suggesting that CD31 and CD34 enhance the channel-forming ability of gastric tumor cells.